Publications related to project ISOLDA – part 5

Since 2020, the ISOLDA consortium has been collaborating to develop improved vaccines against viral infections for older adults. The collaboration has resulted in a number of peer-reviewed articles in academic journals. Over the coming months, we will share these articles in the News section of our website.

Following part 1, part 2, part 3, and part 4 of this blog series, the consortium is proud to present another nine academic publications related to project ISOLDA:

#TitleAuthorsJournalDOI and URL
25Comparison of two antibody screening systems for SARS-CoV-2 antibody detection in recovered and vaccinated subjects - test performance and possible indicators for immunityRebecca Jonczyk, Nils Stanislawski, Lisa K Seiler, Somayeh Ahani, Arne Bueltemeier, Frank Stahl, Sascha Beutel, Holger Blume, Corinna Hauß, Anette Melk, Mira Paulsen, Meike Stiesch, Andreas Winkel, Philipp-Cornelius Pott, Giulietta Saletti, Mariana González-Hernández, Franziska Karola Kaiser, Guus F Rimmelzwaan, Albert D M E Osterhaus, Cornelia BlumeJ Clin Virol10.1016/j.isci.2023.106309 View here
26Signs of immunosenescence correlate with poor outcome of mRNA COVID-19 vaccination in older adultsMiguel Ángel Palacios-Pedrero, Janina M. Jansen, Cornelia Blume, Nils Stanislawski, Rebecca Jonczyk, Antonia Molle, Mariana Gonzalez Hernandez, Franziska K. Kaiser, Klaus Jung, Albert D. M. E. Osterhaus, Guus F. Rimmelzwaan & Giulietta SalettiNature Aging10.1038/s43587-022-00292-y View here
27SARS-CoV-2 ORF8 accessory protein is a virulence factorM Bello-Perez, J Hurtado-Tamayo, A Z Mykytyn, M M Lamers, R Requena-Platek, D Schipper, D Muñoz-Santos, J Ripoll-Gómez, A Esteban, P J Sánchez-Cordón, L Enjuanes, B L Haagmans, I SolamBio10.1128/mbio.00451-23 View here
28SARS-CoV-2 Mac1 is required for IFN antagonism and efficient virus replication in cell culture and in miceYousef M. Alhammad, Srivatsan Parthasarathy, Roshan Ghimire, Anthony R. FehrPNAS10.1073/pnas.2302083120 View here
29FDA-approved Abl/EGFR/PDGFR kinase inhibitors show potent efficacy against pandemic and seasonal influenza A virus infections of human lung explantsRobert Meineke, Sonja Stelz, Maximilian Busch, Christopher Werlein, Mark Kühnel, Danny Jonigk, Guus F Rimmelzwaan, Husni ElbaheshiScience10.1016/j.isci.2023.106309 View here
30Contribution of Host miRNA-223-3p to SARS-CoV-Induced Lung Inflammatory PathologyLucía Morales, Juan Carlos Oliveros, Luis Enjuanes, Isabel SolamBio10.1128/mbio.03135-21 View here
31CBL E3 ubiquitin ligases are key inhibitory regulators in PD-1/LAG-3 co-signaling in human cancers, targeted through bispecific co-blockadeL. Chocarro, L. Fernández-Rubio, M.J. Garcia Granda, E. Blanco Palmeiro, A.I. Bocanegra Gondan, M. Echaide, M. Garnica, M. Zuazo, C. Johnston, C.J. Edwards, J. Leggs, A. Pierce, H. Arasanz, R. Vera, K. Ausin, E. Santamaría, J. Fernández-Irigoyen, G. Kochan, D. EscorsAnnals of Oncology10.1016/j.annonc.2023.09.1518 View here
32Metabolic dyshomeostasis induced by SARS-CoV-2 structural proteins reveals immunological insights into viral olfactory interactionsMercedes Lachén-Montes, Naroa Mendizuri, Karina Ausín, Miriam Echaide, Ester Blanco, Luisa Chocarro, María de Toro, David Escors, Joaquín Fernández-Irigoyen, Grazyna Kochan, Enrique SantamaríaFrontiers in Immunology10.3389/fimmu.2022.866564 View here
33Clinical landscape of LAG-3-targeted therapyL Chocarro, E Blanco, H Arasanz, L Fernández-Rubio, A Bocanegra, M Echaide, M Garnica, P Ramos, G Fernández-Hinojal , R Vera, G Kochan, D EscorsImmuno-oncology Technology10.1016/j.iotech.2022.100079 View here
3440P Identification of a PD-1/LAG-3 co-expression profile in human tumor-infiltrating T cells uncovers a T cell dysfunctionality genetic regulated programmeL. Chocarro, E. Blanco, H. Arasanz, L. Fernández-Rubio, A.I. Bocanegra, M. Echaide, M. Garnica, P. Ramos, S. Piñeiro-Hermida, M.J. García-Granda, R. Vera, E. Santamaría, J. Fernández-Irigoyen, G. Kochan, D. EscorsAnnals of Oncology10.1016/j.annonc.2022.07.067 View here
35Leading Edge: Intratumor Delivery of Monoclonal Antibodies for the Treatment of Solid TumorsEster Blanco, Luisa Chocarro, Leticia Fernández-Rubio, Ana Bocanegra, Hugo Arasanz, Miriam Echaide, Maider Garnica, Sergio Piñeiro-Hermida, Grazyna Kochan, David EscorsInternational Journal of Molecular Sciences10.3390/ijms24032676 View here
36Inhibition of Host Kinase Activity: Effects on Influenza A Virus Infection and Host Cell SignalingRobert MeinekeN/A (Thesis/Dissertation)View here
37Cutting-Edge CAR Engineering: Beyond T CellsLuisa Chocarro, Ester Blanco, Leticia Fernández-Rubio, Hugo Arasanz, Ana Bocanegra, Miriam Echaide, Maider Garnica, Pablo Ramos, Sergio Piñeiro-Hermida, Ruth Vera, Grazyna Kochan, David EscorsBiomedicines10.3390/biomedicines10123035 View here
3855P Clinical landscape of LAG-3-targeted therapyL. Chocarro, E. Blanco, H. Arasanz, A. Bocanegra, L. Fernández-Rubio, M. Echaide, M. Garnica, P. Ramos, G. Fernández-Hinojal, R. Vera, G. Kochan, D. EscorsAnnals of Oncology10.1016/j.annonc.2021.08.2051 View here
39Relevancia del motivo PBM de la proteína E en la replicación y virulencia de los coronavirus.José Manuel Honrubia BelenguerN/A (Thesis/Dissertation)View here
40Human coronavirus-host interactions: pathogenesis and antiviral responseLi WangN/A (Thesis/Dissertation)View here
41Engineering potent live attenuated coronavirus vaccines by targeted inactivation of the immune evasive viral deubiquitinaseSebenzile K. Myeni, Peter J. Bredenbeek, Robert C. M. Knaap, Tim J. Dalebout, Shessy Torres Morales, Igor A. Sidorov, Marissa E. Linger, Nadia Oreshkova, Sophie van Zanen-Gerhardt, Serge A. L. Zander, Luis Enjuanes, Isabel Sola, Eric J. Snijder & Marjolein KikkertNature Communications10.1038/s41467-023-36754-z View here
42Contribution to pathogenesis of accessory proteins of deadly human coronavirusesJesus Hurtado-Tamayo, Ricardo Requena-Platek, Luis Enjuanes, Melissa Bello-Perez, Isabel SolaFrontiers in Cellular and Infection Microbiology10.3389/fcimb.2023.1166839 View here
43Cell type dependent stability and virulence of a recombinant SARS-CoV-2, and engineering of a propagation deficient RNA replicon to analyze virus RNA synthesisLi Wang, María Guzman, Diego Muñoz-Santos, Jose Manuel Honrubia, Jorge Ripoll-Gomez, Rafael Delgado, Isabel Sola, Luis Enjuanes, Sonia ZuñigaFrontiers in Cellular and Infection Microbiology10.3389/fcimb.2023.1268227 View here
44SARS-CoV-2 Mac1 is required for IFN antagonism and efficient virus replication in cell culture and in mice.Yousef M Alhammad, Srivatsan Parthasarathy, Roshan Ghimire, Joseph J O'Connor, Catherine M Kerr, Jessica J Pfannenstiel, Debarati Chanda, Caden A Miller, Robert L Unckless, Sonia Zuniga, Luis Enjuanes, Sunil More, Rudragouda Channappanavar, Anthony R FehrbioRxiv10.1101/2023.04.06.535927 View here
45SARS-CoV-2 ORF8 accessory protein is a virulence factor.M Bello-Perez, J Hurtado-Tamayo, A Z Mykytyn, M M Lamers, R Requena-Platek, D Schipper, D Muñoz-Santos, J Ripoll-Gómez, A Esteban, P J Sánchez-Cordón, L Enjuanes, B L Haagmans, I SolamBio10.1128/mbio.00451-23 View here
46mRNA Vaccines against SARS-CoV-2: Advantages and Caveats.Miriam Echaide, Luisa Chocarro de Erauso, Ana Bocanegra, Ester Blanco, Grazyna Kochan, David EscorsInternational Journal of Molecular Sciences10.3390/ijms24065944 View here
47Oleuropein enhances anti-SARS-CoV-2 T-cell immunity in young and older vaccineesN/AN/A (In preparation)N/A
48PD-1/LAG-3 co-signaling profiling uncovers CBL ubiquitin ligases as key immunotherapy targetsLuisa Chocarro, Ester Blanco, Leticia Fernandez-Rubio, Maider Garnica, Miren Zuazo, Maria Jesus Garcia, Ana Bocanegra, Miriam Echaide, Colette Johnston, Carolyn J Edwards, James Legg, Andrew J Pierce, Hugo Arasanz, Gonzalo Fernandez-Hinojal, Ruth Vera, Karina Ausin, Enrique Santamaria, Joaquin Fernandez-Irigoyen, Grazyna Kochan, David EscorsEMBO Molecular Medicinedoi.org/10.1038/s44321-024-00098-y View here
49Poor virus-specific T-cell responses early after tick-borne encephalitis virus infection correlate with disease severityAmare Aregay,Jan Slunečko, Petra Bogovic, Miša Korva, Katarina Resman Rus, Nataša Knap, Jana Beicht, Mareike Kubinski, Giulietta Saletti, Imke Steffen, Franc Strle, Tatjana Avšič-Županc, Albert D.M.E. Osterhaus, Guus F. RimmelzwaanEmerging Microbes & Infections10.1080/22221751.2024.2317909 View here
50Tick-borne encephalitis vaccine breakthrough infections induce aberrant T cell and antibody responses to non-structural proteinsAmare Aregay, Jan Slunečko, Miša Korva, Petra Bogovic, Katarina Resman Rus, Nataša Knap, Jana Beicht, Mareike Kubinski, Giulietta Saletti, Tatjana Avšič-Županc, Imke Steffen, Franc Strle, Albert D. M. E. Osterhaus & Guus F. Rimmelzwaannpj Vaccines10.1038/s41541-024-00936-7 View here
51Interaction between SARS-CoV PBM and Cellular PDZ Domains Leading to Virus VirulenceJose M Honrubia, Jose R Valverde, Diego Muñoz-Santos, Jorge Ripoll-Gómez, Nuria de la Blanca, Jorge Izquierdo, Marta Villarejo-Torres, Ana Marchena-Pasero, María Rueda-Huélamo, Ivan Nombela, Mercedes Ruiz-Yuste, Sonia Zuñiga, Isabel Sola, Luis EnjuanesViruses10.3390/v16081214 View here
52Fractalkine in Health and DiseaseClaudia Rodriguez, Luisa Chocarro, Miriam Echaide, Karina Ausin, David Escors, Grazyna KochanInternational Journal of Molecular Sciences10.3390/ijms25158007 View here
53Role of Sex and Age in Fatal Outcomes of COVID-19: Women and Older Centenarians Are More ResilientCalogero Caruso, Gabriella Marcon, Giulia Accardi, Anna Aiello, Anna Calabrò, Mattia Emanuela Ligotti, Mauro Tettamanti, Claudio Franceschi, Giuseppina CandoreInternational Journal of Molecular Sciences10.3390/ijms24032638 View here
54Centenarians born before 1919 are resistant to COVID-19Calogero Caruso, Giulia Accardi, Anna Aiello, Anna Calabrò, Mattia Emanuela Ligotti & Giuseppina CandoreAging Clinical and Experimental Research10.1007/s40520-022-02287-6 View here
55Sicilian semi- and supercentenarians: identification of age-related T cell immunophenotype to define longevity traitMattia Emanuela Ligotti, Giulia Accardi, Anna Aiello, Stefano Aprile, Anna Calabrò, Rosalia Caldarella, Calogero Caruso, Marcello Ciaccio, Anna Maria Corsale, Francesco Dieli, Marta Di Simone, Giovanni Maurizio Giammanco, Chiara Mascarella, Arne N Akbar, Serena Meraviglia, Giuseppina CandoreClinical and Experimental Immunology10.1093/cei/uxad074 View here
56Sex and gender affect immune agingAnna Calabrò, Giulia Accardi, Anna Aiello, Calogero Caruso, Giuseppina CandoreFrontiers in Aging10.3389/fragi.2023.1272118 View here
57Sicilian semi- and supercentenarians: age-related NK cell
immunophenotype and longevity trait definition.
Mattia E Ligotti, Giulia Accardi, Anna Aiello, Anna Calabrò, Calogero Caruso, Anna M Corsale, Francesco Dieli, Marta Di Simone, Serena Meraviglia, Giuseppina CandoreTranslational Medicine @ UniSa10.37825/2239-9747.1041 View here
58The Phenotypic Characterization of the Oldest Italian Man from December 28, 2020, to September 23, 2021, A.T., Strengthens the Idea That the Immune System can Play a Key Role in the Attainment of Extreme LongevityGiulia Accardi, Anna Aiello, Stefano Aprile, Anna Calabrò, Rosalia Caldarella, Calogero Caruso, Marcello Ciaccio, Francesco Dieli, Mattia Emanuela Ligotti, Serena Meraviglia, Giuseppina CandoreJournal of Clinical Medicine10.3390/jcm12247591 View here
59Centenarians, semi and supercentenarians,
COVID-19 and Spanish flu: a serological
assessment to gain insight into the resilience
of older centenarians to COVID-19
Claudia Maria Trombetta, Giulia Accardi, Anna Aiello, Anna Calabrò, Calogero Caruso, Mattia Emanuela Ligotti, Serena Marchi, Emanuele Montomoli, Martin Mayora Neto, Nigel Temperton & Giuseppina CandoreImmunity & Ageing10.1186/s12979-024-00450-3 View here
60Senotherapeutics to Counteract Senescent Cells Are Prominent Topics in the Context of Anti-Ageing StrategiesAnna Calabrò, Giulia Accardi, Anna Aiello, Calogero Caruso, Damiano Galimberti, Giuseppina CandoreInternational Journal of Molecular Sciences10.3390/ijms25031792 View here
61Improving flu-vaccination response for older adults.
Preliminary results from ISOLDA study on in vitro model
N/AN/A (Submitted)N/A

Related Posts